Private equity firm Adenia Partners has signed definitive agreements to acquire a majority stake in Egypt’s Parkville Pharmaceuticals from Admaius Capital Partners and the company’s founders, the parties announced on Monday. The transaction, which remains subject to customary closing conditions and regulatory approvals, marks the first exit for Admaius Capital Partners’ current fund. Parkville, founded in 2008 and headquartered in Cairo, operates across the pharmaceutical, cosmeceutical, and nutraceutical sectors. Admaius invested in Parkville alongside its founders, Chairperson Sherif Bassiouny and CEO Mahmoud Farrag, in November 2023. “The dollar returns to our investors are very attractive and demonstrate what is possible when strong market positioning, drive and focus combine with superior execution,” said Marlon Chigwende, Admaius Managing Partner.

Source: Daily News Egypt January 26, 2026 20:44 UTC